VentureBeat May 7, 2024
Dean Takahashi

Neurable raised $13 million for its brain-computer interface (BCI) technology that can work with everyday products.

Boston-based Neurable plans to use this funding round to advance its platform technology with a range of large-scale applications through its BCI AI technology and scaling its licensing business to further development and experimentation across multiple industries

Neurable wants to democratize neurotechnology. The funding came from Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.

With over $30 million raised since its founding, Neurable is working with its licensing partnership network to make easy-to-use neurotechnology a reality, including through the upcoming launch of the Neurable AI-powered MW75 Neuro headphones.

With this new funding, Neurable will continue to expand the build of its platform, giving companies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
Pulse Biosciences names new CEO, reassigns former leader
R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee
How new tariffs on Chinese medical products will affect US healthcare
PCOS infertility treatment developer May Health raises $25M
Medical device instructions need a rewrite, APIC says

Share This Article